M1 for COVID-19

M1 has been reported as potentially beneficial for COVID-19 in the following study.

COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 210+ treatments. We have not reviewed M1 in detail.

Study suggesting benefit with M1

Chhetri et al., Identification of lead inhibitors for 3CLpro of SARS-CoV-2 target using machine learning based virtual screening, ADMET analysis, molecular docking and molecular dynamics simulations, RSC Advances, doi:10.1039/d4ra04502e

Identification of novel drug candidate with appropriate pharmacokinetic properties and drug-likeness for SARS-CoV-2.